,57,58,59 Interestingly, RB1 loss and MYC copy number gain were also negative clinical predictors for EGFR-mutant NSCLC, both in the adjuvant setting59 and in the metastatic resistant setting with an association of transformation to small cell lung cancer.60 Here, MYC is linked to small cell lung carcinoma.